News

Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31
Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary ...
Preeclampsia Drug Market Research Report 2025-2035 | Competitive Analysis of Pharming Group, AMAG Pharmaceuticals, Kyowa Kirin, and Baxter
The global preeclampsia drug market is poised for significant growth due to increasing awareness, advancements in diagnostics, and a higher prevalence of hypertension in pregnant women. Preeclampsia, ...
Best Momentum Stocks to Buy for July 17th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 17th: ProKidney Corp. PROK: This clinical-stage biotechnology company has a Zacks Rank #1 ...
Pharming Group N.V.: Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31
Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the second ...
New Strong Buy Stocks for July 17th
List today: Pharming Group N.V. PHAR: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 7% over the last 60 days. Pharming Group N.V.
The Manila Times5d
Transaction in Own Shares
The Company has instructed Numis Securities Limited (trading for these purposes as Deutsche Numis) as its broker in respect ...